Vascular complications in patients treated with granulocyte colony-stimulating factor (G-CSF)
- 31 December 1993
- journal article
- other
- Published by Elsevier in European Journal Of Cancer
- Vol. 29 (16), 2338-2339
- https://doi.org/10.1016/0959-8049(93)90236-9
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Identification of a functional receptor for granulocyte colony-stimulating factor on platelets.Journal of Clinical Investigation, 1993
- Granulocyte colony-stimulating factor and platelet aggregationThe Lancet, 1993
- Acute arterial thrombosis after escalated-dose methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy with recombinant granulocyte colony-stimulating factor: A possible new recombinant granulocyte colony-stimulating factor toxicityCancer, 1992
- Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: a randomized controlled trialBlood, 1992
- Regulation of leukocyte migration by activation of the leukocyte adhesion molecule-1 (LAM-1) selectinNature, 1991
- MACOP-B and VACOP-B in diffuse large cell lymphomas and MOPP/ABV in Hodgkin's diseaseAnnals of Oncology, 1991
- Hematologic effects of recombinant human granulocyte colony-stimulating factor in patients with malignancyBlood, 1989
- Granulocyte- and granulocyte– macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferateNature, 1989